DEVICE FOR THE AUTOMATIC MONITORING OF GLUCOSE AND CONTROLLED DOSAGE OF INULIN THROUGH MICRONEEDLES AND MICROFUIDIC CHANNELS AND METHOD FOR CONTROLLING THE SAME.
INSTITUTO TECNOLOGICO Y DE ESTUDIOS SUPERIORES DEMONTERREY
发明人:
ALEX ELIAS ZUÑIGA,CIRO ANGEL RODRIGUEZ GONZALEZ,ERIKA GARCIA LOPEZ,HECTOR RAFAEL SILLER CARRILLO
申请号：
MX2012014507
公开号：
MX2012014507A
申请日:
2012.12.12
申请国别(地区):
MX
年份:
2014
代理人:
摘要：
The supply of drugs into the human body has developed novel alternatives of medical dosage, where the controlled and continuous dosing still being a challenge. The device for the automatic monitoring of glucose and controlled dosage of inulin through microneedles and microfluidic channels and method for controlling the same allows drugs to be uniformly released through a microfluidic device, which distributes the drug in the microneedles for being subsequently released in a transdermal form. The device is designed to be located in patients with inulin deficiencies, facilitating the control of the drug in the patient’s life according to the clinical history of the same. The design of the device involves the modularity thereof for facilitating the everyday life of the patient. The six modules of the device include a system for taking blood samples, a sensor, a control module, a flow and pumping divider system, a microneedles patch and a user-control interface. The device includes these modules for the controlled dosage of inulin, through a patch of microneedles which is exchangeable every 10 blood samples, including a refillable deposit that is fastened to the arm of the patient for the continuous dosing and monitoring.El suministro de fármacos en el cuerpo humano ha generado nuevas alternativas de dosificación médica, siento aún un reto la dosificación controlada y continua de medicamentos. El dispositivo para el monitoreo automático de glucosa y dosificación controlada de insulina a través de microagujas y canales microfluídicos y su método de control permite la liberación uniforme de fármacos a través de un dispositivo microfluídico el cual distribuye el medicamento en las microagujas para posteriormente ser liberado de forma transdérmica. El uso de este dispositivo es diseñado para ser colocado en los pacientes con deficiencia de insulina, facilitando el control del medicamento en la vida del paciente de acuerdo al historial clínico del mismo. El diseño del dispos
